Post Hoc Analysis of Phase III Gecacitinib Clinical Trial Outcomes: Enhanced Understanding and Implications
Year: 2024
Type: conference-abstract
Source: Blood
Authors: Yi Zhang, Hu Zhou, Shanshan Suo, Junling Zhuang, Linhua Yang, Aili He, Qingchi Liu, Xin Du, Sujun Gao, Yarong Li, Yan Li, Yuqing Chen, Wen Wu, Huanling Zhu, Guangsheng He, Mei Hong, Qian Jiang, Zhongxing Jiang, Hongmei Jing, Jishi Wang, Na Xu, Lingling Yue, Cuiping Zheng, ZePing Zhou, Chenghao Jin, Xin Li, Lin Liu, Yajing Xu, Dengshu Wu, Feng Zhang, Jin Zhang, Zhijian Xiao, Jie Jin
Institutions: First Affiliated Hospital Zhejiang University, Henan Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Second Hospital of Shanxi Medical University, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an Jiaotong University, Hebei Medical University, First Affiliated Hospital of Hebei Medical University, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Southern Medical University, First Hospital of Jilin University, Jilin University, First Hospital of China Medical University, Second Affiliated Hospital of Jilin University, Henan Provincial People's Hospital, Shanghai Jiao Tong University, Ruijin Hospital, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Sichuan University, West China Hospital of Sichuan University, Jiangsu Province Hospital, Huazhong University of Science and Technology, Peking University People's Hospital, First Affiliated Hospital of Zhengzhou University, Peking University, Peking University Third Hospital, Affiliated Hospital of Guizhou Medical University, Nanfang Hospital, Lanzhou University Second Hospital, Wenzhou Central Hospital, Kunming Medical University, Second Affiliated Hospital of Kunming Medical College, Jiangxi Provincial People's Hospital, Third Xiangya Hospital, The Affiliated Yongchuan Hospital of Chongqing Medical University, Central South University, Xiangya Hospital Central South University, First Affiliated Hospital of Bengbu Medical College, Sir Run Run Shaw Hospital, Zhejiang University, Institute of Hematology & Blood Diseases Hospital
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405034674